We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Rolls Out Paxil CR After Recalls Force Plant Shutdown
GSK Rolls Out Paxil CR After Recalls Force Plant Shutdown
August 10, 2005
Roughly four months after GlaxoSmithKline (GSK) voluntarily halted production of its antidepressant Paxil CR (paroxetine HCl controlled release), the company resumed U.S. sales of the antidepressant.